What Wegovy is and how it is used

Wegovy (semaglutide) is a prescription-only GLP-1 medicine licensed in the UK for weight management, used alongside a reduced-calorie diet and increased physical activity. It is not a standalone fix, and it is not designed to be used on its own. Instead, it is meant to support the everyday changes that already help with weight, appetite and eating patterns.

Semaglutide belongs to a group of medicines called GLP-1 receptor agonists. These mimic a natural gut hormone that helps regulate appetite and how full you feel after eating. Many people find they feel satisfied sooner and stay fuller for longer, which can make it easier to eat less without feeling constantly hungry. If you would like to understand the underlying mechanism in more detail, our explainer on How does Ozempic work? covers the same active ingredient in a related medicine.

Wegovy is given as a once-weekly injection under the skin, usually in the stomach, thigh or upper arm. In the UK, treatment is typically started at a low dose and increased gradually over several weeks. This step-up approach is intended to help your body adjust and to reduce the chance of side effects. NICE has issued guidance on when semaglutide may be considered for weight management within defined criteria, and a clinician will check whether those criteria apply to you.

The known safety profile and common side effects

When people ask "is Wegovy safe?", they are usually asking about two things at once: how likely side effects are, and how serious they tend to be. The reassuring part is that semaglutide has been studied in large clinical trials and is used widely, so its safety profile is reasonably well understood. That does not mean it is risk-free, but it does mean the common issues are recognised and, in most cases, manageable.

The most frequently reported side effects are gastrointestinal, meaning they affect the stomach and gut. These may include:

  • Nausea, particularly in the early weeks or after a dose increase
  • Diarrhoea or constipation
  • Vomiting
  • Indigestion, bloating or burping
  • Feeling unusually full, or a reduced appetite

For many people these effects are mild to moderate and tend to ease over time as the body adjusts, especially when the dose is increased slowly. Simple measures such as eating smaller portions, avoiding very fatty or rich meals, and staying hydrated can help. Other reported effects can include headache, tiredness, dizziness and gallbladder-related problems. This is not a complete list, and the patient information leaflet supplied with the medicine sets out the full range.

Because semaglutide can affect appetite and food intake, it is important to keep eating a balanced diet and to stay well hydrated. If side effects are severe, persistent, or stopping you from eating and drinking normally, it is worth speaking to your prescriber rather than pushing through. If you would like a broader overview, our guide to Common side effects of GLP-1 medications looks at what this class of medicines tends to have in common.

Serious but rare risks and warnings

Alongside the common, generally manageable side effects, there are less frequent but more serious risks that a clinician will weigh up before prescribing. These are uncommon, but they are the reason Wegovy is prescription-only and monitored rather than freely available.

One important warning relates to the thyroid. In animal studies, semaglutide and similar medicines caused thyroid C-cell tumours. It is not known whether this applies to humans in the same way, but as a precaution Wegovy should not be used by anyone with a personal or family history of medullary thyroid carcinoma (a specific type of thyroid cancer), or by anyone with Multiple Endocrine Neoplasia syndrome type 2 (MEN2), a rare inherited condition. If this applies to you or a close relative, it is essential to tell your clinician.

Other serious but uncommon risks that clinicians watch for include:

  • Pancreatitis (inflammation of the pancreas), which can cause severe, persistent tummy pain that may spread to the back. Sudden, severe abdominal pain should be treated as a reason to seek urgent medical advice.
  • Gallbladder problems, including gallstones, particularly with weight change.
  • Dehydration and effects on the kidneys, especially if vomiting or diarrhoea are severe.
  • Low blood sugar (hypoglycaemia), which is more likely if Wegovy is used alongside certain diabetes medicines such as insulin or sulfonylureas.
  • Allergic reactions, which are rare but need prompt attention.

Serious allergic reactions and severe abdominal pain are medical emergencies. If you experience symptoms such as swelling of the face or throat, difficulty breathing, or intense stomach pain, seek urgent medical help. In the UK, suspected side effects from medicines can also be reported through the MHRA Yellow Card scheme, which helps monitor safety over time.

Who should avoid it or take care

Wegovy is not suitable for everyone, and part of what makes it reasonably safe is careful patient selection. It is not licensed for use in children in the same way as adults, and eligibility is based on defined criteria that a clinician will assess.

Wegovy should not be used in pregnancy, and it is generally advised that it is not used while breastfeeding. If you are pregnant, think you might be, or are planning a pregnancy, tell your clinician, as they will usually recommend stopping the medicine in advance. Effective contraception is something your prescriber may discuss with you.

Extra care, closer monitoring, or an alternative approach may be needed if you have:

  • A history of pancreatitis or gallbladder disease
  • Type 2 diabetes, particularly if you take insulin or other blood-sugar-lowering medicines
  • Significant kidney, liver or heart problems
  • Diabetic eye disease (diabetic retinopathy)
  • A history of certain eating patterns or conditions
  • Other medicines that may interact with semaglutide

This is not a full list, which is exactly why a proper assessment matters. Wegovy is one of several GLP-1 options, and different medicines suit different people. You may find it helpful to compare with our guide Is Mounjaro safe?, which looks at a related weight-management medicine.

Why suitability is a clinician decision

The honest answer to "is Wegovy safe?" is that safety is always about the right medicine, for the right person, at the right time, with the right monitoring. A medicine that is a sensible option for one person may not be appropriate for another, and only a full assessment can tell the two apart.

Before prescribing, a UK-registered clinician will typically review your medical history, current medicines, any relevant family history, and your individual goals. They will explain what to expect, how to use the injection, and what to watch for, and they will arrange follow-up so that your progress and any side effects can be reviewed. This ongoing monitoring is a core part of using GLP-1 medicines responsibly rather than a one-off transaction.

If you are considering Wegovy, the most helpful next step is a conversation with a qualified prescriber who can look at your whole picture. This article is patient education and general information, not a recommendation to start any specific medicine. A UK-registered clinician will advise based on your individual circumstances, and that personalised assessment is what turns a general safety profile into a decision that is right for you.